Psychological symptoms in healthcare workers following the COVID-19 pandemic and relationship to long-term cardiovascular risk
COVID-19 大流行后医护人员的心理症状及其与长期心血管风险的关系
基本信息
- 批准号:10365638
- 负责人:
- 金额:$ 79.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAmerican Heart AssociationAnxietyAtherosclerosisBuffersCOVID-19COVID-19 pandemicCOVID-19 patientCOVID-19 treatmentCardiovascular DiseasesCardiovascular systemCaringCase StudyCessation of lifeDataDatabasesDevelopmentDisease OutbreaksEmergency Department patientEnrollmentEnsureEnvironmentExposure toFibrinogenFrightFutureHealthHealth PersonnelHospitalizationHospitalsHourIndividualInterventionLife ExpectancyLinkLong COVIDMeasuresMental HealthNew YorkNew York CityParticipantPersonal SatisfactionPhysiciansPhysiologicalPoliciesPost-Traumatic Stress DisordersPrevalencePsyche structurePsychological StressPsychological TestsPsychophysiologyPublic HealthRiskSafetyScheduleSleeplessnessSocietiesSpecific qualifier valueStressSubgroupSurveysSustainable DevelopmentSymptomsTestingVaccinesWorkacute careacute traumatic stress disorderbasecardiovascular disorder riskcardiovascular healthcardiovascular risk factorcopingcoronavirus diseaseexperiencefollow-uphealinghospital organizationindexinginfection ratemedical specialtiespandemic diseasephysical conditioningprospectiveprotective factorspsychologicpsychological distresspsychological outcomespsychological symptomrecruitsafety netshift work
项目摘要
Over the past year, the entire world has been upended by the COVID-19 pandemic. As of February 2021, there
have been over 112 million confirmed cases and over 2.5 million deaths globally. In New York City, the initial
US epicenter of the pandemic, there have been >700,000 cases, >89,000 hospitalizations, and >29,000
deaths. Healthcare workers (HCWs) have experienced alarming rates of anxiety, stress, and insomnia due to
COVID-19, which are likely to persist beyond the pandemic. In the proposed work, we will examine the
presence and predictors of long-term psychological symptoms and the consequences for cardiovascular health
among emergency department (ED) HCWs following the COVID-19 pandemic. This work is necessary to
understand the scope of the problem and to inform efforts to protect the health of these frontline HCWs who
have risked their lives to ensure our safety. Pre-COVID, ED HCWs were already known to be at greater
psychological risk than nearly every other subgroup of clinicians. Psycho-physiologic stress factors have been
dramatically magnified during the COVID period, in what has been referred to as a “parallel pandemic” of
surging mental and physical harm faced by HCWs. It is critical to understand the presence of sustained
psychological symptoms seen in HCWs who treated COVID patients, as well as downstream impacts on
cardiovascular health. Our preliminary work showed that HCWs experienced significant acute psychological
distress during the initial COVID peak in New York City. In a survey of hospital HCWs conducted in April
2020, we found high rates of acute stress disorder (65%), anxiety (36%), and insomnia (70%). Early evidence
points to persistence of psychological symptoms. In these participants, 25% experienced post-traumatic stress
disorder (PTSD) and 39% experienced insomnia at a 10 week follow-up. In the proposed study, we will (1)
examine the prevalence and predictors of sustained psychological symptoms in ED HCWs who provided care
during the COVID pandemic; (2) characterize the relationship of psychological symptoms to 3-year progression
of atherosclerotic cardiovascular disease (ASCVD) risk; and (3) examine a potential protective factor (i.e.,
resilient coping) in the development of COVID-related psychological symptoms. To achieve these aims, we will
conduct a prospective 3-year study of psychological and cardiovascular health in ED HCWs exposed to some of
the highest COVID case rates in the world. At study baseline (Year 0) and at each annual follow-up (Years 1-3),
we will conduct a thorough psychological test battery that includes measures of COVID-related PTSD, COVID-
related fear, insomnia, and resilient coping. Each participant’s ASCVD risk score will be computed annually.
Our primary exposure and predictor of psychological symptoms will be the computed “Covid burden,”
quantified as the number of shifts worked between March 1, 2020 (date of our hospital’s index case) and study
enrollment, in which COVID admissions exceeded 15% of total ED patients. Findings will inform interventions
to protect mental and physical wellbeing in HCWs as we navigate this and future public health crises.
在过去的一年里,截至 2021 年 2 月,整个世界都被 COVID-19 大流行所颠覆。
纽约市的确诊病例已超过 1.12 亿,死亡人数超过 250 万人。
美国是大流行的中心,已有超过 700,000 例病例,超过 89,000 例住院治疗,超过 29,000 例
医护人员 (HCW) 由于焦虑、压力和失眠而经历了惊人的死亡人数。
COVID-19 很可能在大流行结束后持续存在,在拟议的工作中,我们将研究它。
长期心理症状的存在和预测因素以及对心血管健康的影响
在 COVID-19 大流行后,这项工作对于急诊室 (ED) 医护人员来说是必要的。
了解问题的范围,并告知保护这些一线医护人员健康的努力
在新冠疫情发生之前,急诊室医护人员冒着生命危险确保我们的安全。
心理风险高于几乎所有其他亚组的防御者 心理生理压力因素。
在新冠疫情期间,这种情况急剧放大,被称为“平行流行病”
医护人员面临的精神和身体伤害激增,了解持续性伤害的存在至关重要。
治疗新冠肺炎患者的医护人员中出现的心理症状,以及对患者的下游影响
我们的初步工作表明,医护人员经历了显着的急性心理健康。
纽约市新冠疫情最初高峰期间的困扰 在四月份对医院医护人员进行的一项调查中。
2020 年,我们发现急性应激障碍 (65%)、焦虑 (36%) 和失眠 (70%) 的发病率很高。
指出这些参与者中 25% 的人经历过创伤后压力。
在 10 周的随访中,我们将 (1) 进行随访。
检查提供护理的急诊室医护人员持续心理症状的患病率和预测因素
(2) 描述心理症状与3年进展的关系
动脉粥样硬化性心血管疾病 (ASCVD) 风险;(3) 检查潜在的保护因素(即,
弹性应对)在新冠病毒相关心理症状的发展中的作用 为了实现这些目标,我们将
对接触某些物质的急诊医护人员的心理和心血管健康进行了一项为期 3 年的前瞻性研究
在研究基线(第 0 年)和每年的随访(第 1-3 年)中,新冠病例发生率是世界上最高的。
我们将进行全面的心理测试,其中包括与新冠肺炎相关的创伤后应激障碍(PTSD)、新冠肺炎-
每年都会计算每位参与者的 ASCVD 风险评分。
我们对心理症状的主要暴露和预测将是计算出的“新冠负担”,
量化为 2020 年 3 月 1 日(我们医院索引病例的日期)与研究之间的轮班次数
入院人数中,新冠肺炎入院人数超过急诊科患者总数的 15%。调查结果将为干预措施提供依据。
在我们应对当前和未来的公共卫生危机时,保护医护人员的身心健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernard P. Chang其他文献
Young children's beliefs about the stability of traits: protective optimism?
幼儿对特质稳定性的信念:保护性乐观?
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:4.6
- 作者:
Kristi L. Lockhart;Bernard P. Chang;T. Story - 通讯作者:
T. Story
Somatosensory processing in the biological relatives of schizophrenia patients: a signal detection analysis of two-point discrimination.
精神分裂症患者生物亲属的体感处理:两点辨别的信号检测分析。
- DOI:
10.1037/0021-843x.110.3.433 - 发表时间:
2001-08-01 - 期刊:
- 影响因子:4.6
- 作者:
Bernard P. Chang;M. Lenzenweger - 通讯作者:
M. Lenzenweger
Accuracy of the Denver-II in developmental screening.
Denver-II 在发育筛查中的准确性。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:8
- 作者:
F. Glascoe;K. E. Byrne;L. Ashford;K. Johnson;Bernard P. Chang;Bryan Strickland - 通讯作者:
Bryan Strickland
Somatosensory processing and schizophrenia liability: proprioception, exteroceptive sensitivity, and graphesthesia performance in the biological relatives of schizophrenia patients.
体感处理和精神分裂症倾向:精神分裂症患者生物学亲属的本体感觉、外感受敏感性和书写感觉表现。
- DOI:
10.1037/0021-843x.114.1.85 - 发表时间:
2005-02-01 - 期刊:
- 影响因子:4.6
- 作者:
Bernard P. Chang;M. Lenzenweger - 通讯作者:
M. Lenzenweger
Methodological excursions in pursuit of a somatosensory dysfunction in schizotypy and schizophrenia
寻找精神分裂症和精神分裂症体感功能障碍的方法学探索
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:0
- 作者:
M. Lenzenweger;K. Nakayama;Bernard P. Chang;J. Hooley - 通讯作者:
J. Hooley
Bernard P. Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernard P. Chang', 18)}}的其他基金
Psychological symptoms in healthcare workers following the COVID-19 pandemic and relationship to long-term cardiovascular risk
COVID-19 大流行后医护人员的心理症状及其与长期心血管风险的关系
- 批准号:
10558672 - 财政年份:2022
- 资助金额:
$ 79.88万 - 项目类别:
Daily personal light exposure patterns and sleep in emergency department healthcare workers (administrative supplement to R01 HL146911)
急诊科医护人员的每日个人光照模式和睡眠(R01 HL146911 的行政补充)
- 批准号:
10666252 - 财政年份:2022
- 资助金额:
$ 79.88万 - 项目类别:
The Identification of Modifiable Emergency Department and Sleep Factors Contributing to Psychological and Cardiovascular Risk in Clinicians
确定导致临床医生心理和心血管风险的可修改急诊室和睡眠因素
- 批准号:
10319929 - 财政年份:2020
- 资助金额:
$ 79.88万 - 项目类别:
The Identification of Modifiable Emergency Department and Sleep Factors Contributing to Psychological and Cardiovascular Risk in Clinicians
确定导致临床医生心理和心血管风险的可修改急诊室和睡眠因素
- 批准号:
10547767 - 财政年份:2020
- 资助金额:
$ 79.88万 - 项目类别:
The Identification of Modifiable Emergency Department and Sleep Factors Contributing to Psychological and Cardiovascular Risk in Clinicians
确定导致临床医生心理和心血管风险的可修改急诊室和睡眠因素
- 批准号:
9886646 - 财政年份:2020
- 资助金额:
$ 79.88万 - 项目类别:
Testing a rapid outpatient management strategy on PTSD, cardiovascular and rehospitalization risk in TIA and minor stroke survivors evaluated in the Emergency Department
测试针对 PTSD、TIA 心血管和再住院风险以及急诊科评估的轻微中风幸存者的快速门诊管理策略
- 批准号:
10208939 - 财政年份:2018
- 资助金额:
$ 79.88万 - 项目类别:
Testing a rapid outpatient management strategy on PTSD, cardiovascular and rehospitalization risk in TIA and minor stroke survivors evaluated in the Emergency Department
测试针对 PTSD、TIA 心血管和再住院风险以及急诊科评估的轻微中风幸存者的快速门诊管理策略
- 批准号:
9754258 - 财政年份:2018
- 资助金额:
$ 79.88万 - 项目类别:
Testing a rapid outpatient management strategy on PTSD, cardiovascular and rehospitalization risk in TIA and minor stroke survivors evaluated in the Emergency Department
测试针对 PTSD、TIA 心血管和再住院风险以及急诊科评估的轻微中风幸存者的快速门诊管理策略
- 批准号:
10448410 - 财政年份:2018
- 资助金额:
$ 79.88万 - 项目类别:
Testing a rapid outpatient management strategy on PTSD, cardiovascular and rehospitalization risk in TIA and minor stroke survivors evaluated in the Emergency Department
测试针对 PTSD、TIA 心血管和再住院风险以及急诊科评估的轻微中风幸存者的快速门诊管理策略
- 批准号:
10208939 - 财政年份:2018
- 资助金额:
$ 79.88万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Improving care transitions for Veterans withsocial needs
改善有社会需求的退伍军人的护理过渡
- 批准号:
10638723 - 财政年份:2023
- 资助金额:
$ 79.88万 - 项目类别:
Treating Drivers of Suicide in Primary Care using Jaspr Health TABA Supplement
使用 Jaspr Health TABA 补充剂治疗初级保健中的自杀驱动者
- 批准号:
10805635 - 财政年份:2023
- 资助金额:
$ 79.88万 - 项目类别:
COVID-19 Pandemic-related Changes in the Child Tax Credit and Effects on Behavioral Health for Medicaid-enrolled Adolescents
与 COVID-19 大流行相关的儿童税收抵免变化及其对参加医疗补助的青少年行为健康的影响
- 批准号:
10686628 - 财政年份:2023
- 资助金额:
$ 79.88万 - 项目类别:
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
- 批准号:
10759550 - 财政年份:2023
- 资助金额:
$ 79.88万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 79.88万 - 项目类别: